Details for New Drug Application (NDA): 018839
✉ Email this page to a colleague
NDA 018839 describes BETADERM, which is a drug marketed by Roaco and is included in one NDA. Additional details are available on the BETADERM profile page.
The generic ingredient in BETADERM is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
The generic ingredient in BETADERM is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 018839
| Tradename: | BETADERM |
| Applicant: | Roaco |
| Ingredient: | betamethasone valerate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018839
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | EQ 0.1% BASE | ||||
| Approval Date: | Jun 30, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
